beta

ALDX

Aldeyra Therapeutics Inc.

Aldx

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Aldeyra Therapeutics Inc is biotechnology company focused on the development of products for inflammation, inborn errors of metabolism, and other diseases, related to endogenously generated toxic and pro-inflammatory chemical species known as aldehydes.

Market Cap: 142 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.aldeyra.com

Shares Outstanding: 19.1 Million

Float: 18.8 Million

Dividend: 0.0 (0.0%)

Beta: 0.624496

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 375 Thousand

Ethical Flags

Animal testing

Longest drawdown: 920 trading days

From: 2015-01-30 To: 2018-09-25

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud